The Natural History of a Patient with COVID-19 Pneumonia and Silent Hypoxemia
Total Page:16
File Type:pdf, Size:1020Kb
CASE IN POINT The Natural History of a Patient With COVID-19 Pneumonia and Silent Hypoxemia Nicholas Hornstein, MD; Gilad M. Jaffe, MD; Kelley Chuang, MD; Jaime Betancourt, MD; and Guy W. Soo Hoo, MD A patient who declined all interventions, including oxygen, and recovered highlights the importance of treating the individual instead of clinical markers and provides a time course for recovery from pneumonia and severe hypoxemia. Author affiliations n less than a year, COVID-19 has infected benefit in those patients with COVID-19 can be found at the nearly 100 million people worldwide and who require oxygen or mechanical venti- end of the article. caused more than 2 million deaths and lation, but their impact on the progression Correspondence: I Guy Soo Hoo counting. Although the infection fatality of respiratory failure and need for intuba- ([email protected]) rate is estimated to be 1% and the case fa- tion are undetermined. tality rate between 2% and 3%, COVID-19 There also are reports of patients who Fed Pract. 2021;38(4). Published online has had a disproportionate effect on the report no signs of respiratory distress or April 12, 2021 older population and those with comorbidi- dyspnea with their COVID-19 pneumo- doi:10.12788/fp.0100 ties. Some of these findings are mirrored in nia despite profound hypoxemia or high the US Department of Veterans Affairs (VA) oxygen requirements. Various terms, in- population, which has seen a higher case cluding silent hypoxemia or happy hy- fatality rate.1-4 poxia, are descriptive of the demeanor of As a respiratory tract infection, the these patients, and treatment has invari- most dreaded presentation is severe pneu- ably included oxygen.15,16 Nevertheless, monia with acute hypoxemia, which may low oxygen measurements have generally rapidly deteriorate to acute respiratory dis- prompted higher levels of supplemental tress syndrome (ARDS) and respiratory oxygen or more invasive therapies. failure.5-7 This possibility has led to early Treatment rendered may obscure intubation strategies aimed at preempting the trajectory of response, which is im- this rapid deterioration and minimizing portant to understand to better posi- viral exposure to health care workers. In- tion options for invasive therapies and tubation rates have varied widely with ex- other therapeutics. We recently encoun- tremes of 6 to 88%.8,9 tered a patient with a course of illness However, this early intubation strategy that represented the natural history of has waned as some of the rationale behind COVID-19 pneumonia with low oxygen its endorsement has been called into ques- levels (referred to as hypoxemia for con- tion. Early intubation bypasses alternatives sistency) that highlighted several issues of to intubation; high-flow nasal cannula ox- management. ygen, noninvasive ventilation, and awake proning are all effective maneuvers in the Case Presentation appropriate patient.10,11 The use of first- A 62-year-old undomiciled woman with line high-flow nasal cannula oxygen and morbid obesity, prediabetes mellitus, long- noninvasive ventilation has been widely standing schizophrenia, and bipolar disor- reported. Reports of first-line use of high- der presented to our facility for evaluation of flow nasal cannula oxygen has not dem- dry cough and need for tuberculosis clear- onstrated inferior outcomes, nor has the ance for admittance to a shelter. She ap- timing of intubation, suggesting a signifi- peared comfortable and was afebrile with cant portion of patients could benefit from blood pressure 111/74 mm Hg, heart rate a trial of therapy and eventually avoid in- 82 beats per minute. Her respiratory rate tubation.11-14 Other therapies, such as sys- was 18 breaths per minute, but the pulse ox- temic corticosteroids, confer a mortality imetry showed oxygen saturation of 70 to 184 • FEDERAL PRACTITIONER • APRIL 2021 mdedge.com/fedprac 75% on room air at rest. A chest FIGURE 1 Admission and Discharge Chest X-rays X-ray showed bibasilar infiltrates (Figure 1), and a rapid COVID-19 nasopharyngeal polymerase chain reaction (PCR) test returned pos- itive, confirmed by a second PCR test. Baseline inflammatory mark- ers were elevated (Figure 2). In ad- dition, the serum interleukin-6 also was elevated to 66.1 pg/mL (nor- mal < 5.0), erythrocyte sedimenta- tion rate elevated to 69 mm/h, but serum procalcitonin was essen- A, On admission, findings were consistent with COVID-19 pneumonia, including bibasilar infil- tially normal (0.22 ng/mL; normal trates. B, Prior to discharge, improvement of infiltrates can be seen. < 20 ng/mL) as was the serum lac- FIGURE 2 Trends in Peripheral Capillary Oxygen Saturation and tate (1.4 mmol/L). Inflammatory Markers The patient was admitted to the intensive care unit (ICU) for Oxygen Saturation Lactate Dehydrogenase close monitoring in anticipation of the possibility of decompensation 90 400 based on her age, hypoxia, and el- 17 80 U/L 200 evated inflammatory markers. Be- Percent sides a subsequent low-grade fever 70 0 (100.4 oF) and lymphopenia (man- 0 10 20 30 0 10 20 30 ual count 550/uL), she remained Days Days clinically unchanged. Throughout D-Dimer C-Reactive Protein her hospitalization, she maintained 15 20 a persistent psychotic delusion that 10 she did not have COVID-19, refus- 10 ug/mL ing all medical interventions, in- 5 mg/dL cluding a peripheral IV line and 0 0 0 10 20 30 0 10 20 30 supplemental oxygen for the en- Days Days tire duration. Extensive efforts to identify family or a surrogate deci- Ferritin Lymphocytes sion maker were unsuccessful. After 1,500 consultation with Psychiatry, Bio- 2,000 1,000 Ethics, and hospital leadership, ng/mL the patient was deemed to lack 500 cell/uL 1,000 decision-making capacity regard- 0 10 20 30 0 10 20 30 ing treatment or disposition and Days Days was placed on a psychiatric hold. Lowest recorded awake daily peripheral capillary oxygen saturation and inflammatory markers However, since any interventions gathered during hospitalization showed profound hypoxemia and inflammation. Dotted lines indicate upper limits of normal (lower limit in case of lymphocytes). Not included: elevated against her will would require se- interleukin-6 (66.1 pg/mL [normal < 5.0]) and negative procalcitonin. dation, IV access, and potentially increase the risk of nosocomial COVID-19 transmission, she was allowed in the low 80% range, but on day 12, read- to remain untreated and was closely moni- ings were > 90% and remained > 90% for tored for symptoms of worsening respiratory the remainder of her hospitalization. There- failure. fore, shortly after hospital day 12, she was Over the next 2 weeks, her hypoxemia, in- clinically stable for discharge from acute flammatory markers, and the infiltrates on care to a subacute facility, but this required imaging resolved (Figure 2). The lowest daily documentation of the clearance of her viral awake room air pulse oximetry readings are infection. She refused to undergo a subse- reported, initially with consistent readings quent nasopharyngeal swab but allowed an mdedge.com/fedprac APRIL 2021 • FEDERAL PRACTITIONER • 185 COVID-19 Pneumonia TABLE 1 Pulse Oximetry PaO2 Conversion well tolerated in a variety of conditions. A common example are patients with chronic Pulse Partial Pressure of O2 Oximetry, % Under Ideal Circumstances, mm Hg obstructive pulmonary disease. Long-term mortality benefits of continuous supplemen- 90 60 tal oxygen are well established in specific populations, but the threshold for correc- 85 50 tion in the acute setting remains a case-by- case decision. This decision is complex and 80 44 is based on more than an absolute number or the amount of oxygen required to achieve a 75 40 threshold level of oxygenation. The PaO2/FIO2 (fraction of inspired oxy- oropharyngeal COVID-19 PCR swab, which gen) is a common measure used to address was negative. She remained stable and severity of disease and oxygen requirements. unchanged for the remainder of her It also has been used to define the sever- hospitalization, awaiting identification of ity of ARDS, but the ratio is based on intu- a receiving facility and was able to be dis- bated and mechanically ventilated patients charged to transitional housing on day 38. and may not translate well to those not on assisted ventilation. Treatment with supple- DISCUSSION mental oxygen also involves entrained air The initial reports of COVID-19 pneumo- with associated imprecision in oxygen deliv- nia focused on ARDS and respiratory failure e r y. 18 For this discussion, the patient’s admis- requiring mechanical ventilation with less sion PaO2/FIO2 on room air would have been emphasis on those with lower severity of ill- between 190 and 260. Coupled with the bi- ness. This was heightened by health care lateral infiltrates on imaging, there was justi- systems that were overwhelmed with large fied concern for progression to severe ARDS. number of patients while faced with lim- Her presentation would have met most of ited supplies and equipment. Given the the epidemiologic criteria used in initial case risk to patients and providers of crash in- finding for severe COVID-19 cases, including tubations, some recommended early intu- a blood oxygen saturation ≤ 93%, PaO2/FIO2 bation strategies.3 However, the natural < 300 with infiltrates involving close to if not history of COVID-19 pneumonia and the exceeding 50% of the lung. threshold for intubation of these patients With COVID-19 pneumonia, the patho- remain poorly defined despite the cre- logic injury to the alveoli resembles that of ation of prognostic tools.17 This patient’s any viral pneumonia with recruitment of pre- persistent hypoxemia and elevated in- dominantly lymphocytic inflammatory cells flammatory markers certainly met mark- that fill the alveoli, derangements in ventila- ers of disease associated with a high risk of tion/perfusion mismatch as the core mech- progression.